Cica-Huntek Chemical Technology Taiwan Co AI Stock Analysis
Cica-Huntek Chemical Technology Taiwan Co (6725) AI Stock Analysis
Cica-Huntek Chemical Technology Taiwan Co
(TPEx:6725)
The score reflects a financially sound company caught in a severe technical downtrend. Fundamentals are mixed-to-positive: rapid revenue growth, a low-leverage balance sheet (0.21 debt-to-equity) and 17.6% ROE are offset by sharp margin compression that cut profit roughly 30% and by inconsistent cash conversion, with operating cash flow covering only about half of reported earnings. Technicals are the key drag — the price sits far below all major moving averages with deeply negative MACD and oversold momentum readings, signalling continued selling pressure. Valuation provides the main offset, with an 11.3 P/E and a near-5% dividend yield offering support, though those metrics rest on declining earnings. Investors should look for stabilisation in margins and cash flow, plus evidence of a technical base, before the stock warrants a higher rating.
Cica-Huntek Chemical Technology Taiwan Co (6725) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 6.59B
- Dividend Yield
- 4.08%
- Average Volume (3M)
- 88.94K
- Price to Earnings (P/E)
- 13.5
- Beta (1Y)
- 1.14
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- TW
- Employees
- 362
- Sector
- General
- Sector Strength
- 55
- Industry
- Industrial - Machinery
Cica-Huntek Chemical Technology Taiwan Co Business Overview & Revenue Model
Company Description
Cica-Huntek Chemical Technology Taiwan Co., Ltd. specializes in providing chemical management solutions across Asia. The company's operations span the design, development, manufacturing, and sale of essential chemical supply systems. Their product ra...
Cica-Huntek Chemical Technology Taiwan Co Financial Statement Overview
Summary
Cica-Huntek blends strong growth with a conservative balance sheet, but earnings quality is slipping. Revenue has more than tripled since 2022 (NT$1.19bn to NT$3.82bn), and the balance sheet scores well (76) on equity nearly doubling to NT$2.44bn and debt-to-equity falling to just 0.21. However, the income statement (63) shows sharp margin compression — gross margin down to 23.0% from 30.8% and net margin to 11.2% from 19.5% — driving net income about 30% lower to NT$429m despite higher sales. Cash flow is the weakest link (50), with operating cash flow swinging from NT$573m to negative NT$56m and back to NT$213m, covering only about half of reported net income. ROE of 17.6% remains respectable but fell steeply from 43.6%.
Income Statement
63PositiveBalance Sheet
76PositiveCash Flow
50Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.80B | 3.82B | 3.15B | 2.81B | 1.19B | 943.51M |
| Gross Profit | 699.87M | 877.30M | 972.76M | 802.13M | 230.46M | 180.90M |
| EBITDA | 594.10M | 636.84M | 823.31M | 676.23M | 154.92M | 127.34M |
| Net Income | 439.94M | 429.16M | 616.28M | 516.17M | 110.98M | 90.37M |
Balance Sheet | ||||||
| Total Assets | 4.61B | 4.32B | 3.03B | 3.11B | 1.36B | 1.05B |
| Cash, Cash Equivalents and Short-Term Investments | 847.03M | 1.63B | 947.73M | 1.38B | 351.15M | 271.81M |
| Total Debt | 434.67M | 505.27M | 543.10M | 689.34M | 19.73M | 107.57M |
| Total Liabilities | 2.24B | 1.88B | 1.61B | 2.08B | 792.35M | 563.85M |
| Stockholders Equity | 2.37B | 2.44B | 1.41B | 1.02B | 566.02M | 487.15M |
Cash Flow | ||||||
| Free Cash Flow | -517.41M | 168.21M | -60.39M | 417.59M | 226.17M | 74.82M |
| Operating Cash Flow | -228.08M | 213.13M | -55.54M | 572.58M | 228.99M | 76.03M |
| Investing Cash Flow | -331.96M | 313.77M | 337.27M | -806.27M | -170.75M | -36.77M |
| Financing Cash Flow | 869.80M | 547.21M | -401.02M | 596.91M | -142.40M | 13.34M |
Cica-Huntek Chemical Technology Taiwan Co Peers Comparison
Overall Rating
TW:520976Outperform
TW:153569Neutral
TW:695364Neutral
TW:472163Neutral
TW:338860Neutral
TW:672560Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | TWD 5.67B | 11.38 | ― | 5.94% | 4.58% | 32.53% | |
| 69Neutral | TWD 5.55B | 12.21 | ― | 6.73% | -23.64% | -8.34% | |
| 64Neutral | TWD 6.27B | 19.42 | ― | 2.87% | 23.38% | 39.41% | |
| 63Neutral | TWD 5.16B | 13.59 | ― | 3.34% | 13.33% | 84.75% | |
| 60Neutral | TWD 5.74B | 12.71 | ― | 4.66% | 6.26% | 37.04% | |
| 60Neutral | TWD 6.37B | 13.51 | ― | 4.08% | ― | ― | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:6725 | Cica-Huntek Chemical Technology Taiwan Co | 171.50 | -73.61 | -30.03% | |
| TW:1535 | China Ecotek Corp. | 44.55 | -7.17 | -13.86% | |
| TW:3388 | Topco Technologies Corp. | 71.60 | 11.84 | 19.82% | |
| TW:4721 | Mechema Chemicals International Corp. | 68.80 | 1.43 | 2.12% | |
| TW:5209 | CTCI Advanced Systems Inc. | 218.00 | 59.87 | 37.86% | |
| TW:6953 | Gudeng Equipment Co., Ltd. | 209.00 | 27.42 | 15.10% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
